Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients Scheduled for Surgery to Remove Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a monoclonal antibody therapy in patients with ovarian cancer scheduled for surgery was terminated; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Ludwig Institute for Cancer Research | Conditions: Ovarian Cancer | Phase 1 | Status: TERMINATED | Results posted: 2021-08-12